Luskin, M. R. and Leonard, J. T. (2025) “Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes”, Haematologica. Pavia, Italy, 110(11), pp. 2560-2561. doi: 10.3324/haematol.2025.288068.